白介素35(IL35)檢測試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Interleukin 35 (IL35)
- 編號USCC008Mu
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時長2h, 40min
- 檢測范圍1.37-1,000pg/mL
- 靈敏度最小可檢測劑量小于等于0.52pg/mL.
- 樣本類型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 1814 ¥ 2592 ¥ 11664 ¥ 22032 ¥ 181440
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
實(shí)驗(yàn)結(jié)果圖
-
標(biāo)準(zhǔn)曲線圖
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
本試劑盒用于檢測白介素35(IL35)，經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制，不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測，因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的白介素35(IL35)（加標(biāo)樣品），重復(fù)測定并計(jì)算其均值，回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 84-91 | 87 |
| EDTA plasma(n=5) | 96-105 | 101 |
| heparin plasma(n=5) | 96-105 | 101 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差：取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次，分別計(jì)算不同濃度樣本的平均值及SD值。
批間差：選取3個不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定，每個樣本使用同一試劑盒重復(fù)測定8次，分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的白介素35(IL35)，并倍比稀釋成1:2，1:4，1:8，1:16的待測樣本，線性范圍即為稀釋后樣本中白介素35(IL35)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 89-104% | 96-104% | 83-94% | 88-96% |
| EDTA plasma(n=5) | 84-91% | 98-105% | 91-99% | 95-105% |
| heparin plasma(n=5) | 84-99% | 95-102% | 94-103% | 79-92% |
穩(wěn)定性
經(jīng)測定，試劑盒在有效期內(nèi)按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響，實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致，尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備；
2. 加樣（標(biāo)準(zhǔn)品及樣本）100µL，37°C孵育1小時；
3. 吸棄，加檢測溶液A100μL，37°C孵育1小時；
4. 洗板3次；
5. 加檢測溶液B100µL，37°C孵育30分鐘；
6. 洗板5次；
7. 加底物100µL，37°C孵育10分鐘；
8. 讀數(shù)。
實(shí)驗(yàn)原理
將白介素35(IL35)抗體包被于96孔微孔板中，制成固相載體，向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本，其中的白介素35(IL35)與連接于固相載體上的抗體結(jié)合，然后加入生物素化的白介素35(IL35)抗體，將未結(jié)合的生物素化抗體洗凈后，加入HRP標(biāo)記的親和素，再次徹底洗滌后加入底物。加入底物后會產(chǎn)生輝光型光信號。發(fā)射光強(qiáng)度和樣品中的白介素35(IL35)呈正相關(guān)。用化學(xué)發(fā)光儀測定相對光單位（RLU），計(jì)算樣品濃度。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPC008Mu02 | 白介素35(IL35)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPC008Mu01 | 白介素35(IL35)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPC008Mu01 | 白介素35(IL35)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAC008Mu01 | 白介素35(IL35)多克隆抗體 | IHC |
| USEC008Mu | 白介素35(IL35)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UMEC008Mu | 白介素35(IL35)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCC008Mu | 白介素35(IL35)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMC008Mu | 白介素35(IL35)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Oncology Letters | Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia. [PubMed: 22783403] |
| Journal of Maternal-Fetal and Neonatal Medicine | Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease [Pubmed: 24175856] |
| Journal of Reproductive Immunology | What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? [Pubmed: 24368037] |
| Human Immunology | The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia [ScienceDirect: S0198885913005776] |
| Folia Biologica (Praha) | Gene Expression of Subunits of the IL-12 Family Cytokines in moDCs Derived In Vitro from the Cord Blood of Children of Healthy and Allergic Mothers [Pubmed:24785110] |
| Molecular Medicine Reports | Function of interleukin?17 and ?35 in the blood of patients with hepatitis B?related liver cirrhosis [Pubmed:25323532] |
| Rom J Morphol Embryol. | The regular distribution and expression pattern of immunosuppressive cytokine IL-35 in mouse uterus during early pregnancy [Pubmed:25611266] |
| Journal of Immunotherapy | Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity [PubMed: 25962106] |
| PLOS ONE | Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis [PubMed: 26204444] |
| Rheumatology (Oxford) | Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease [PubMed: 26231346] |
| Cytokine | Anti-inflammatory effects of interleukin-35 in acquired aplastic anemia [PubMed: 26282938] |
| J Biol Chem | Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway [PubMed: 26085094] |
| Br J Haematol | Interleukin 35 may contribute to the loss of immunological self‐tolerance in patients with primary immune thrombocytopenia [PubMed: 25640666] |
| Autoimmunity Reviews | New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature [Pubmed:26876383] |
| Clinical research | Increased plasma concentrations of interleukin 35 in patients with coronary artery disease [Journal:-19] |
| Clinical?Rheumatology | The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis [pubmed:27502600] |
| Respiratory?Medicine | Enhanced LPS-induced activation of IL-27 signalling in sarcoidosis [pubmed:27492538] |
| International Journal of Molecular Medicine | Effects?of an?intravitreal?injection?of?interleukin-35-expressing?plasmid?on?pro-inflammatory?andanti-inflammatory?cytokines. [pubmed:27460435] |
| 上?？谇会t(yī)學(xué) | IL-35在牙周炎及口腔扁平苔蘚中的表達(dá)及相關(guān)性分析 [QK:98604X] |
| Reproductive Sciences | Upregulation of Interleukin 35 in Patients With Endometriosis Stimulates Cell Proliferation [pubmed:28659009] |
| EXPERIMENTAL AND THERAPEUTIC?MEDICINE | IL?35 may maintain homeostasis of the immune microenvironment in periodontitis [issn:2542-3975] |
| The Journal of Rheumatology | Synoviocytes-derived Interleukin 35 Potentiates B Cell Response in Patients with Osteoarthritis and Rheumatoid Arthritis [pubmed:29247146] |
| Cellular & Molecular Immunology | Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro [pubmed:28713164] |
| Molecular?Medicine?Reports | Lower level of IL?35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test?positive hemocytopenia. [pubmed:29257310] |
| Asian pacific journal of allergy and immunology | Evaluation of serum interleukin- 35 level in children with persistent asthma. [pubmed:27996283] |
| PLoS One | Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio [pubmed:29236782] |
| Hepatology Communications | Significant association between FOXP3 gene polymorphism and steroid-resistant acute rejection in living donor liver transplantation [10.1002/hep4.1052] |
| International Journal of Clinical and Experimental Medicine | Clinical significance of IL-35 expression in the progression of clear cell renal cell carcinoma [ISSN:1940-5901] |
| OncoTargets and Therapy | Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy. [pubmed:28761357] |
| Annals of Rheumatic Diseases? | AB0734 Serum il-35 levels in systemic sclerosis and relationship with clinical features [10.1136:annrheumdis-2018-eular.2605] |
| Tohoku?Journal of Experimental?Medicine | Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients [Pubmed:29576585] |
| Turkish?Journal Of?Medical?Sciences | The impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility [Pubmed:29914245] |
| Oncotarget | Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas [Pubmed:29721156] |
| Journal of Clinical Rheumatology | Serum Interleukin 35 Levels in Systemic Sclerosis and Relationship With Clinical Features. [Pubmed: 30431486] |
| Oncology Letters | Interleukin?35 is associated with the tumorigenesis and progression of prostate cancer [] |
| Journal of Clinical Investigation | Plasmacytoid dendritic cells protect against immune-mediated acute liver injury via IL-35 [Pubmed: 31264967] |
| Cells | CD4+ FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired [Pubmed: 32111105] |
| Cytokine | Interleukin-35 in idiopathic inflammatory myopathies [Pubmed: 33128920] |
| FEBS Open Bio | IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1, and IGFBP1 [Pubmed: 33064893] |
| Cancer Cell International | Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity [Pubmed: 33041668] |
| Journal of Neuroinflammation | Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain [Pubmed: 32375811] |
| Int Immunopharmacol | Association of IL-35 expression and gene polymorphisms in rheumatoid arthritis [33307515] |
| Archives of Medical Science | Decreased interleukin-35 levels and CD4+ EBI3+ T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab) [33488880] |
| Asia Pac Allergy | Anti-inflammatory roles of interleukin-35 in the pathogenesis of Japanese cedar pollinosis [34386410] |
| Int Immunopharmacol | Pentosan Polysulfate Sodium augments the therapeutic effect of 5-Aminosalicylic Acid in DSS colitis model; the role of IL-35 expression [Pubmed:35247859] |
| Biology and Medical Researches | Association of three single nucleotide polymorphisms of interleukin-35 for detection and prediction of women with breast cancer in Erbil city [] |
| Research Square | Analysis of IL-10 and IL-35 in DPP-4 inhibitor-related bullous pemphigoid [] |
留言咨詢
